Tobramycin Cystic Fibrosis Approved 27/03/2013 Yes (pseudomonas lung infection) Ranibizumab Diabetic macular Approved 27/02/2013 Yes oedema Apixaban Stroke & Systemic Approved 27/02/2013 Yes embolism Verumafenib Locally Adv. Or Approved 12/12/2012 Yes metastatic BRAF V600 mutation-positive unresectable metastatic Ipilimumab Metastatic melanoma Approved 12/12/2012 Yes Ivabradine Heart Failure II - IV Approved 28/11/2012 Yes Mannitol Cystic Fibrosis Approved 28/11/2012 Yes Botulinum toxin A Chronic migraine Approved 27/11/2012 Yes Denosumab Bone Metastases for Approved 24/10/2012 Yes solid tumours Alteplase Acute ischaemic stoke Approved 26/09/2012 Yes Rivaroxaban deep vein thrombosis Approved 25/07/2012 Yes and prevention of recurrent deep vein thrombosis and pulmonary embolism Abiraterone (Zytiga) Metastatic Castration Approved 27/06/2012 Yes resistant Prostate Ca Erlotinib NSCLC with EGFR TA258 Approved 27/06/2012 Yes activating mutations Rivaroxaban Stroke prevention in AF Approved 23/05/2012 Yes Bocepravir Genotype 1 chronic Approved 25/04/2012 Yes Hepatitis C Telaprevir Genotype 1 chronic Approved 25/04/2012 Yes Hepatitis C
Tobramycin Cystic Fibrosis (pseudomonas lung infection) Approved 27/03/2013 Yes Ranibizumab Diabetic macular oedema Approved 27/02/2013 Yes Apixaban Stroke & Systemic embolism Approved 27/02/2013 Yes Verumafenib Locally Adv. Or metastatic BRAF V600 mutation-positive unresectable metastatic Approved 12/12/2012 Yes Ipilimumab Metastatic melanoma Approved 12/12/2012 Yes Ivabradine Heart Failure II - IV Approved 28/11/2012 Yes Mannitol Cystic Fibrosis Approved 28/11/2012 Yes Botulinum toxin A Chronic migraine Approved 27/11/2012 Yes Denosumab Bone Metastases for solid tumours Approved 24/10/2012 Yes Alteplase Acute ischaemic stoke Approved 26/09/2012 Yes Rivaroxaban deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism Approved 25/07/2012 Yes Abiraterone (Zytiga) Metastatic Castration resistant Prostate Ca Approved 27/06/2012 Yes Erlotinib NSCLC with EGFR activating mutations TA258 Approved 27/06/2012 Yes Rivaroxaban Stroke prevention in AF Approved 23/05/2012 Yes Bocepravir Genotype 1 chronic Hepatitis C Approved 25/04/2012 Yes Telaprevir Genotype 1 chronic Hepatitis C Approved 25/04/2012 Yes
NICE-TA-Adherence-Check-list-September-2013-HAST.docx